The Use of Gonadotropin-Releasing Hormone Agonist Does Not Affect the Development of Cardiovascular Disease in Prostate Cancer Patients: a Nationwide Population-Based Cohort Study
- Author:
Myungsun SHIM
1
;
Woo Jin BANG
;
Cheol Young OH
;
Yong Seong LEE
;
Seong Soo JEON
;
Hanjong AHN
;
Young Su JU
;
Jin Seon CHO
Author Information
- Publication Type:Original Article
- Keywords: Antineoplastic Agents; Prostatic Neoplasm; Adverse Effects; Cardiovascular Diseases
- MeSH: Antineoplastic Agents; Cardiovascular Diseases; Cohort Studies; Comorbidity; Diagnosis; Drug Therapy; Follow-Up Studies; Gonadotropin-Releasing Hormone; Humans; Incidence; Male; Morinda; Multivariate Analysis; Myocardial Ischemia; National Health Programs; Observational Study; Passive Cutaneous Anaphylaxis; Prostate; Prostatic Neoplasms; Social Class
- From:Journal of Korean Medical Science 2020;35(4):47-
- CountryRepublic of Korea
- Language:English
- Abstract:
